open search
close
Internationales Arbeitsrecht Neueste Beiträge United States

US employers get the green light to offer incentives for COVID-19 vaccinations: what are the rules?

Print Friendly, PDF & Email
New guidance from the US Equal Employment Opportunity Commission gives the go-ahead to employers to offer incentives to employees to get vaccinated and provide educational material to encourage vaccination, under certain conditions.
The new guidance

On 28 May 2021, the US Equal Employment Opportunity Commission (EEOC) updated its guidance relating to employers’ obligations and limitations in responding to the COVID-19 pandemic in the workplace. Most notably, the EEOC’s newly revised guidance gave the go-ahead to employers seeking to incentivise COVID-19 vaccinations in the workplace.  

In doing so, the EEOC clarified that offering vaccination incentives to employees who receive a vaccination on their own will not violate federal anti-discrimination laws, including the Americans with Disabilities Act (ADA) and Title II of the Genetic Information Nondiscrimination Act of 2008 (GINA), so long as the employees receive the vaccinations voluntarily and the employers maintain confidentiality of any employee vaccination records provided by their employees in conformity with the ADA. As such, an employer’s request for documentation confirming that an employee received a COVID-19 vaccination is not a disability-related inquiry that would violate the ADA.  

The EEOC’s guidance clarifies that employers may provide employees and their family members with information to educate them about COVID-19 vaccines in an effort to raise awareness about the benefits of vaccination and can even administer vaccines to their employees. 

However, employers who choose to administer or use an agent to administer vaccines are prohibited from providing incentives that are so substantial that they are considered coercive. The EEOC’s reasoning behind this limitation is that offering a substantial incentive may pressure employees to disclose protected medical information, as is typically required when completing health screenings prior to receiving a vaccination and may potentially run afoul of the ADA. While the guidance does not include examples of coercive incentives, employers may avoid any potential ramifications relating to this limitation by not administering vaccinations personally or through an agent and instead accepting confirmation that an employee was vaccinated by an independent provider. 

The guidance also clarifies that employers may only offer incentives to their employees who receive vaccinations and may not offer incentives in exchange for an employee’s family member receiving a vaccination. Because such incentives may potentially result in an employer receiving genetic information such as an employee’s family medical history, it may potentially run afoul of GINA and should be avoided. However, employers administering vaccines may still offer to vaccinate their employees’ family members so long as an incentive is not offered; the vaccinations are voluntary; all medical information provided is used solely for the pre-vaccination screening process, is kept confidential, and is not provided to any individuals who make employment decisions for the employees; and the employer receives prior written authorisation from the family member before the family member provides any medical information. 

Takeaway for employers

Employers are permitted to implement COVID-19 vaccination incentive programs in the workplace. Employers may either provide incentives:  

  • in exchange for confirmation that an employee received a vaccination by a third-party provider; or  
  • upon administering a vaccination, either personally or through an agent, so long as the incentive is not so substantial that it is considered coercive. 

 Employers who are concerned about the potential repercussions relating to the limitation on the second option should simply employ the first option, as requesting confirmation of a COVID-19 vaccination is permissible under the ADA.  

While providing incentives to employees who receive COVID-19 vaccinations is a positive way to promote vaccination, educating employees about the benefits of vaccination goes hand-in-hand with any such incentive programs. 

Employers also should keep in mind that other federal, state, and local laws may place more stringent restrictions on employers with regard to COVID-19 vaccination incentives. 

Ius Laboris




Ius Laboris is a leading international employment law practice combining the world’s leading employment, labour and pension firms. Our role lies in sharing insights and helping clients to navigate the world of labour and employment law successfully.
Verwandte Beiträge
Internationales Arbeitsrecht Neueste Beiträge

Diversity and inclusion: what’s new and what’s coming up?

Promoting diversity and inclusion in the workplace is a fast-moving area of law and HR practice. What’s new across the world? Harassment In the wake of the #MeToo movement, many jurisdictions implemented or improved harassment protections and that trend is still evident across the world. In Denmark the government and social partners have entered into a wide-ranging agreement on sexual harassment to foster change. Consisting…
Individualarbeitsrecht Kollektivarbeitsrecht Neueste Beiträge Restrukturierung

Wir ziehen um! Zieht ihr mit? – Herausforderungen von Standortwechseln des Arbeitgebers

Das neue Bürogebäude ist fast fertiggestellt. Die Umzugskisten im alten Bürogebäude werden bereits gepackt. Was kann jetzt noch schiefgehen? Ein Umzug stellt auch für Arbeitgeber stets den Beginn eines neuen Abschnitts dar. Wir zeigen auf, woran Arbeitgeber denken sollten, damit auch möglichst alle Arbeitnehmer mitziehen. Verschiedene Gründe bewegen Arbeitgeber zu einem Standortwechsel. So können große Restrukturierungen oder auch nur das bloße Auslaufen des Bürogebäudemietvertrags einen…
Internationales Arbeitsrecht

It’s finally here: adequacy decision on EU-US data transfers

Data transfers from the EU to the US will now be easier for many companies, following a long-awaited decision from the European Commission. More than a year after the first announcement of the Trans-Atlantic Data Privacy Framework, the European Commission adopted its adequacy decision on the EU-US Data Privacy Framework (DPF) on 10 July 2023, which entered into force with immediate effect. Transfers to US companies signed up…
Abonnieren Sie den kostenfreien KLIEMT-Newsletter.
Jetzt anmelden und informiert bleiben.

 

Die Abmeldung ist jederzeit möglich.

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert